StockWatch
·
Medical Specialities
Loan & DebtMay 1, 2026, 04:22 PM

Quest Diagnostics Prices $500M Senior Notes Due 2036 at 5.000%

AI Summary

Quest Diagnostics announced the pricing of a public offering of $500 million aggregate principal amount of 5.000% senior notes due 2036. The company expects to receive the net proceeds on May 6, 2026, and intends to use them for general corporate purposes. This may include the repayment of its $500 million 3.45% Senior Notes maturing on June 1, 2026.

Key Highlights

  • Quest Diagnostics priced $500 million aggregate principal amount of senior notes.
  • The senior notes have a 5.000% interest rate and are due in 2036.
  • Net proceeds are expected upon closing on May 6, 2026.
  • Proceeds will be used for general corporate purposes.
  • May include repayment of $500 million 3.45% Senior Notes maturing June 1, 2026.
  • Underwriters include Goldman Sachs, J.P. Morgan, and Mizuho Securities.